Linked Life Data

19213455

Source:http://linkedlifedata.com/resource/pubmed/id/19213455

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-2-13
pubmed:abstractText
According to a multitude of international studies the safety of general drug treatment practice is not up to standard. It has been demonstrated that about 50% of adverse drug reactions are avoidable and that their main cause are medication errors. Such errors have often been related to dosing and non-consideration of contraindications and the individual patient's risk profile. In order to resolve this unacceptable situation pharmacovigilance has to be strengthened. Pharmacovigilance in this context does not only imply the assessment and collection of adverse drug reactions, but also the communication of treatment risks to the medical community as well as to pharmacists and patients, and the development and implementation of intelligent electronic prescribing systems. The Federal Government of Germany in co-operation with the Drug Commission of the German Medical Association has decided on a bunch of about 40 single measures to enhance drug safety in this country. This project was issued in November 2007 by the Federal Ministry of Health. The Drug Commission will be responsible for the co-ordination of any future actions.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1865-9217
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
582-6; discussion 593, 606-8
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Improving drug safety in Germany: an alliance between the government and the medical profession].
pubmed:affiliation
Robert-Rössle-Klinik im HELIOS Klinikum Berlin-Buch, Klinik für Hämatologie, Onkologie u. Tumorimmunologie, Charité, Campus Berlin-Buch. bmoe@zedat.fu-berlin.de
pubmed:publicationType
Journal Article, English Abstract